Nugenerex Immuno-oncology, Inc. Current Assets
Nugenerex Immuno-oncology, Inc. had Current Assets of $5.15 million as of 2021-04-30, per its 10-Q filed 2021-06-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2021-06-14
- 2021-04-30: Assets, Current $5.15M.
- 2021-01-31: Assets, Current $1.80M.
- 2020-10-31: Assets, Current $20.04K.
- 2020-07-31: Assets, Current $84.00.
| Period end | Assets, Current |
|---|---|
| 2021-04-30 | $5.15M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $1.80M 10-Q · filed 2021-03-12 |
| 2020-10-31 | $20.04K 10-Q · filed 2020-12-15 |
| 2020-07-31 | $84.00 10-Q · filed 2021-06-14 |
| 2020-04-30 | $129.00 10-Q · filed 2020-06-19 |
| 2020-01-31 | $174.00 10-Q · filed 2020-06-17 |
| 2019-07-31 | $389.00 10-Q · filed 2020-06-19 |